A burst of unfavorable or confusing publicity often prompts users of prescription medications to take swift actions that can hurt those medications' brand perception as well as market share, according to researchers at Phoenix Healthcare, a USA-based Phoenix Marketing International practice.
A recently-released Phoenix study, entitled "Impact of Publicity on Consumer Perceptions and Actions in the Cholesterol Medication Category," also demonstrated that doctors who treat such users are often hard pressed to respond with the latest information to a flurry of questions and requests for assistance.
Such events create opportunities for competitors to convey positive reinforcement for their brands and take advantage of market turmoil.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze